ATE156841T1 - Cs-peptide von p. falciparum als allgemeines t- zellen-epitop - Google Patents
Cs-peptide von p. falciparum als allgemeines t- zellen-epitopInfo
- Publication number
- ATE156841T1 ATE156841T1 AT89108618T AT89108618T ATE156841T1 AT E156841 T1 ATE156841 T1 AT E156841T1 AT 89108618 T AT89108618 T AT 89108618T AT 89108618 T AT89108618 T AT 89108618T AT E156841 T1 ATE156841 T1 AT E156841T1
- Authority
- AT
- Austria
- Prior art keywords
- falciparum
- peptide
- cell epitope
- mhc
- immunogenic compositions
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 241000223960 Plasmodium falciparum Species 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108700018351 Major Histocompatibility Complex Proteins 0.000 abstract 3
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract 3
- 102000054766 genetic haplotypes Human genes 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000282412 Homo Species 0.000 abstract 1
- 102000043131 MHC class II family Human genes 0.000 abstract 1
- 108091054438 MHC class II family Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
- F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
- F02B75/00—Other engines
- F02B75/02—Engines characterised by their cycles, e.g. six-stroke
- F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
- F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888812214A GB8812214D0 (en) | 1988-05-24 | 1988-05-24 | Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE156841T1 true ATE156841T1 (de) | 1997-08-15 |
Family
ID=10637401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89108618T ATE156841T1 (de) | 1988-05-24 | 1989-05-12 | Cs-peptide von p. falciparum als allgemeines t- zellen-epitop |
Country Status (11)
Country | Link |
---|---|
US (1) | US5114713A (de) |
EP (1) | EP0343460B1 (de) |
JP (1) | JP2761402B2 (de) |
AT (1) | ATE156841T1 (de) |
AU (1) | AU627459B2 (de) |
CA (1) | CA1340472C (de) |
DE (1) | DE68928251T2 (de) |
DK (1) | DK250589A (de) |
GB (1) | GB8812214D0 (de) |
NZ (1) | NZ229146A (de) |
ZA (1) | ZA893702B (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2031197A1 (en) * | 1989-04-12 | 1990-10-13 | James P. Tam | Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine |
GB8924438D0 (en) * | 1989-10-31 | 1989-12-20 | Hoffmann La Roche | Vaccine composition |
US5547669A (en) * | 1989-11-03 | 1996-08-20 | Immulogic Pharma Corp | Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I |
IT1241395B (it) * | 1990-04-02 | 1994-01-10 | Eniricerche Spa | Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria |
CH683101A5 (de) * | 1990-09-18 | 1994-01-14 | Biotech Australia Pty Ltd | T-Zellen-Epitope. |
DE4102042A1 (de) * | 1991-01-24 | 1992-07-30 | Bayer Ag | Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide |
DK0614465T3 (da) * | 1991-11-16 | 1999-09-27 | Smithkline Beecham Biolog | Hybridprotein mellem CS fra Plasmodium og HBsAg |
US6169171B1 (en) | 1992-02-27 | 2001-01-02 | Smithkline Beecham Biologicals (S.A.) | Hybrid protein between CS from plasmodium and HBSAG |
US5928902A (en) * | 1992-02-27 | 1999-07-27 | Smithkline Beecham Biologicals (S.A.) | Hybrid protein between CS from plasmodium and HBsAg |
GB9215780D0 (en) * | 1992-07-24 | 1992-09-09 | Univ London Pharmacy | Peptide compounds |
BR9306984A (pt) | 1992-08-27 | 1999-01-12 | Deakin Res Ltd | Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo |
US5674977A (en) * | 1993-02-05 | 1997-10-07 | The Ontario Cancer Institute | Branched synthetic peptide conjugate |
JP3795914B2 (ja) * | 1993-04-27 | 2006-07-12 | ユナイテッド・バイオメディカル・インコーポレイテッド | ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器 |
US5759551A (en) * | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
WO1995000540A1 (en) * | 1993-06-18 | 1995-01-05 | Robert Webber | Synthetic carrier and immunogen |
DK96493D0 (da) * | 1993-08-26 | 1993-08-26 | Mouritsen Og Elsner Aps | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
AU707083B2 (en) * | 1993-08-26 | 1999-07-01 | Bavarian Nordic Inc. | Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes |
US20050049197A1 (en) * | 1993-09-14 | 2005-03-03 | Epimmune Inc. | Induction of immune response against desired determinants |
US6413935B1 (en) * | 1993-09-14 | 2002-07-02 | Epimmune Inc. | Induction of immune response against desired determinants |
ES2318848T3 (es) * | 1993-09-14 | 2009-05-01 | Pharmexa Inc. | Peptidos que se unen a pan dr para potenciar la respuesta inmunitaria. |
GB9422294D0 (en) * | 1994-11-04 | 1994-12-21 | Peptide Therapeutics Ltd | Peptides for anti-allergy treatment |
US5773003A (en) * | 1995-03-31 | 1998-06-30 | Immulogic, Inc. | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
PT814843E (pt) * | 1995-03-31 | 2004-04-30 | Xenova Res Ltd | Conjugados de hapteno-transportador para utilizacao na terapia de abuso de drogas |
US6410022B1 (en) | 1995-05-01 | 2002-06-25 | Avant Immunotherapeutics, Inc. | Modulation of cholesteryl ester transfer protein (CETP) activity |
EP0831881B1 (de) | 1995-06-06 | 2003-03-12 | Avant Immunotherapeutics, Inc. | Cetp zur erhöhung des hdl-cholesterol-gehalts |
US6284533B1 (en) | 1996-05-01 | 2001-09-04 | Avant Immunotherapeutics, Inc. | Plasmid-based vaccine for treating atherosclerosis |
US6846808B1 (en) | 1996-05-01 | 2005-01-25 | Avant Immunotherapeutics, Inc. | Plasmid-based vaccine for treating atherosclerosis |
WO1998031382A1 (en) * | 1997-01-21 | 1998-07-23 | New York University | Universal t-cell epitopes for anti-malarial vaccines |
EP0884327B1 (de) | 1997-06-11 | 2001-03-14 | The School Of Pharmacy, University Of London | Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung |
US20030232055A1 (en) * | 2000-07-31 | 2003-12-18 | Ruslan Medzhitov | Innate immune system-directed vaccines |
US20030175287A1 (en) * | 2001-01-03 | 2003-09-18 | Yale University | Innate immune system-directed vaccines |
US7491690B2 (en) * | 2001-11-14 | 2009-02-17 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
US7371719B2 (en) * | 2002-02-15 | 2008-05-13 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
US7554021B2 (en) * | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
ATE541580T1 (de) | 2003-12-05 | 2012-02-15 | Univ Northwestern | Selbst anordnende peptid-amphiphile und relevante verfahren für die abgabe von wachstumsfaktor |
WO2005070959A2 (en) * | 2004-01-23 | 2005-08-04 | Vievax Corp. | Compositions comprising immune response altering agents and methods of use |
KR20070100948A (ko) * | 2005-01-21 | 2007-10-15 | 노오쓰웨스턴 유니버시티 | 세포의 캡슐화 방법 및 조성물 |
CA2598251A1 (en) * | 2005-03-04 | 2006-09-14 | Northwestern University | Angiogenic heparin binding peptide amphiphiles |
US8076295B2 (en) * | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
JP5697447B2 (ja) * | 2007-08-15 | 2015-04-08 | サーカッシア リミテッド | アレルゲンに対する脱感作のためのペプチド |
US7642125B2 (en) * | 2007-09-14 | 2010-01-05 | Macronix International Co., Ltd. | Phase change memory cell in via array with self-aligned, self-converged bottom electrode and method for manufacturing |
WO2010086743A2 (en) | 2009-02-02 | 2010-08-05 | Chrontech Pharma Ab | Compositions and methods that enhance an immune response |
JP2012523463A (ja) * | 2009-04-13 | 2012-10-04 | ノースウエスタン ユニバーシティ | 軟骨再生のための新規なペプチドベースの足場およびその使用方法 |
US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
WO2014186409A1 (en) | 2013-05-15 | 2014-11-20 | Chrontech Pharma Ab | Immunogenic compositions for inhibiting hepatitis d virus |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ213303A (en) * | 1984-09-12 | 1988-09-29 | Univ New York | Plasmodium protein, dna sequence and vaccine |
US4826957A (en) * | 1985-07-12 | 1989-05-02 | New York University | Immunogenic recombinant yeast expression product and method for purifying it |
US4886782A (en) * | 1987-02-26 | 1989-12-12 | The United States Of America As Represented By The Department Of Health And Human Services | Malarial immunogen |
US5028425A (en) * | 1988-07-07 | 1991-07-02 | The United States Of America As Represented By The Department Of Health And Human Services | Synthetic vaccine against P. falciparum malaria |
GB8819209D0 (en) * | 1988-08-12 | 1988-09-14 | Research Corp Ltd | Polypeptide & dna encoding same |
-
1988
- 1988-05-24 GB GB888812214A patent/GB8812214D0/en active Pending
-
1989
- 1989-05-11 CA CA000599474A patent/CA1340472C/en not_active Expired - Fee Related
- 1989-05-12 AT AT89108618T patent/ATE156841T1/de not_active IP Right Cessation
- 1989-05-12 EP EP89108618A patent/EP0343460B1/de not_active Expired - Lifetime
- 1989-05-12 DE DE68928251T patent/DE68928251T2/de not_active Expired - Fee Related
- 1989-05-16 NZ NZ229146A patent/NZ229146A/en unknown
- 1989-05-17 ZA ZA893702A patent/ZA893702B/xx unknown
- 1989-05-18 US US07/353,427 patent/US5114713A/en not_active Expired - Fee Related
- 1989-05-22 AU AU35046/89A patent/AU627459B2/en not_active Ceased
- 1989-05-23 DK DK250589A patent/DK250589A/da not_active Application Discontinuation
- 1989-05-24 JP JP1129037A patent/JP2761402B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE68928251D1 (de) | 1997-09-18 |
AU3504689A (en) | 1989-11-30 |
AU627459B2 (en) | 1992-08-27 |
EP0343460A2 (de) | 1989-11-29 |
DE68928251T2 (de) | 1998-03-12 |
JP2761402B2 (ja) | 1998-06-04 |
US5114713A (en) | 1992-05-19 |
EP0343460A3 (de) | 1991-07-31 |
CA1340472C (en) | 1999-03-30 |
NZ229146A (en) | 1994-09-27 |
JPH0242099A (ja) | 1990-02-13 |
EP0343460B1 (de) | 1997-08-13 |
ZA893702B (en) | 1990-02-28 |
DK250589D0 (da) | 1989-05-23 |
GB8812214D0 (en) | 1988-06-29 |
DK250589A (da) | 1989-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE156841T1 (de) | Cs-peptide von p. falciparum als allgemeines t- zellen-epitop | |
TR200403064T2 (tr) | Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler. | |
DE69529219T2 (de) | Helicobacter proteine und impstoffe | |
BR9708387A (pt) | Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada. | |
DE69233772D1 (de) | T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe) | |
ATE486887T1 (de) | Trägerprotein eines polyepitops | |
ES2074950A1 (es) | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. | |
DK0427347T3 (da) | Syntetiske peptider, der kan anvendes som universelle bærere til fremstilling af immunogene konjugater, og anvendelse deraf til udvikling af syntetiske vacciner | |
BR9910973A (pt) | Vacina | |
HUP0101464A2 (hu) | Mutáns rekombináns allergének | |
BR0314373A (pt) | Produto imunogênico estável para a indução de anticorpos contra uma ou várias proteìnas antigênicas em um indivìduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico | |
ATE413191T1 (de) | Verwendung of interleukin-1 mutein als impfstoffadjuvans | |
BR0308860A (pt) | Fator viii modificado | |
EA199900627A1 (ru) | Универсальные т-клеточные эпитопы, используемые для получения антималярийных вакцин | |
DE69018926D1 (de) | Vakzine gegen Bordetella. | |
DE69031351D1 (de) | Zubereitungen und behandlungen von pneumonia in tieren | |
BR0207015A (pt) | Eritropoientina modificada (epo) com imunogenicidade reduzida | |
BR0207014A (pt) | Antagonista de receptor de interleucina-1 modificada (il-1ra) com imunogenicidade reduzida. | |
SE9604296D0 (sv) | New pharmaceutical formulation of polypeptides | |
FI933210A0 (fi) | Avirulent vaccin mot rabies | |
Skjødt et al. | Isolation and characterization of chicken and turkey beta2-microglobulin | |
HUP0100130A2 (hu) | Rekombináns Mycoplasma hyopneumoniae vakcina | |
PT99923A (pt) | Processo para a preparacao de proteinas hibridas de plasmodium falciparum que contem sequencias dos antigenios da malaria hrpii e serp e de composicoes farmaceuticas que contem estas proteinas | |
Good et al. | T-cell antigenic sites of the malaria circumsporozoite protein | |
AR012896A1 (es) | Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |